School of Biomedical Engineering, Research and Engineering Center of Biomedical Materials, Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei, 230032, P. R. China.
School of Food and Biological Engineering, Hefei University of Technology, Hefei, 230009, China.
Adv Healthc Mater. 2022 Nov;11(21):e2201023. doi: 10.1002/adhm.202201023. Epub 2022 Sep 4.
The intimate relationship between bacteria and tumors has triggered a lot of activities in the development and design of bioactive materials to concurrently respond to antitumor and antibacterial demands. Herein, a pseudocatalytic hydrogel (AM-I@Agar) with intrinsic antibacterial and photothermal activities, synthesized by incorporating prefabricated amylose-iodine nanoparticles into low-melting-point agarose hydrogel, is explored as a bioactive agent for local treatment of subcutaneous abscesses and breast tumors. The AM-I@Agar hydrogel depicts the ability of pseudocatalytic O generation from H O to alleviate hypoxia. Meanwhile, the AM-I@Agar hydrogel exhibits temperature self-regulation features, beneficial for avoiding thermal injury during photothermal therapy owing to thermochromic properties. Upon local injection into a subcutaneous abscess, methicillin-resistant Staphylococcus aureus is effectively eliminated by the AM-I@Agar hydrogel, and complete skin recovery is achieved in 8 d, demonstrating much better antibacterial effects compared with penicillin, a small-molecule antibiotic. AM-I/5-FU@Agar hydrogel, obtained after loading 5-fluorouracil (5-FU), significantly inhibits tumors in both normal 4T1 tumor-bearing mice and MRSA-infected 4T1 tumor-bearing mice models via a synergistic photothermal-chemo effect, and shows treatment efficiency superior to that achieved with photothermal therapy or 5-FU alone. This work provides a concept for the design and development of bioactive agents for potential management of bacteria-associated cancer.
细菌和肿瘤之间的密切关系激发了许多活动,以开发和设计生物活性材料,同时满足抗肿瘤和抗菌的需求。在此,我们探索了一种具有内在抗菌和光热活性的拟酶水凝胶(AM-I@Agar),它是通过将预制的直链淀粉-碘纳米颗粒掺入低熔点琼脂糖水凝胶中合成的,可作为局部治疗皮下脓肿和乳腺癌的生物活性药物。AM-I@Agar 水凝胶描绘了从 H2O 中产生拟酶 O2的能力,以减轻缺氧。同时,AM-I@Agar 水凝胶具有温度自调节特性,有利于避免光热疗法中的热损伤,因为它具有热致变色特性。当局部注射到皮下脓肿中时,AM-I@Agar 水凝胶有效地消除了耐甲氧西林金黄色葡萄球菌,并且在 8 天内实现了完全皮肤恢复,与小分子抗生素青霉素相比,具有更好的抗菌效果。负载 5-氟尿嘧啶(5-FU)后得到的 AM-I/5-FU@Agar 水凝胶通过协同光热化学作用,显著抑制了正常 4T1 荷瘤小鼠和耐甲氧西林金黄色葡萄球菌感染 4T1 荷瘤小鼠模型中的肿瘤,并且治疗效率优于单独进行光热疗法或 5-FU 治疗的效果。这项工作为设计和开发用于潜在管理细菌相关癌症的生物活性药物提供了一个概念。